NCT03531424

Brief Summary

The purpose of this study is to compare revascularization strategy and its immediate results after augmented-reality computed tomography angiography (CTA) guided vs. standard angiography guided percutaneous coronary intervention (PCI) in native coronary lesions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable coronary-artery-disease

Timeline
Completed

Started Apr 2018

Shorter than P25 for not_applicable coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 25, 2018

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

May 8, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 21, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

May 22, 2018

Status Verified

May 1, 2018

Enrollment Period

4 months

First QC Date

May 8, 2018

Last Update Submit

May 19, 2018

Conditions

Keywords

Coronary StenosisPercutaneous Coronary InterventionStentsComputed Tomography AngiographyAugmented Reality

Outcome Measures

Primary Outcomes (2)

  • Stent length

    Length of the stented segment

    1 day

  • Predicted stent diameter

    Predicted final stent diameter according to a compliance chart

    1 day

Secondary Outcomes (15)

  • Nominal stent diameter

    1 day

  • Number of stents

    1 day

  • Predilation

    1 day

  • Postdilation

    1 day

  • Maximal balloon pressure

    1 day

  • +10 more secondary outcomes

Study Arms (2)

Angiographic guided PCI

ACTIVE COMPARATOR

Angiographic guided PCI is coronary revascularization based on stand-alone angiography.

Procedure: Angiographic guided PCI

CTA guided PCI

EXPERIMENTAL

CTA guided PCI is coronary revascularization based on systematic use of CTA plus coronary angiography.

Procedure: Augmented-Reality CTA guided PCI

Interventions

Angiographic guided PCI is coronary revascularization based on stand-alone angiography.

Angiographic guided PCI

Augmented-Reality CTA guided PCI is coronary revascularization based on systematic use of CTA datasets displayed in augmented-reality glass plus coronary angiography.

CTA guided PCI

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with documented obstructive CAD defined as the presence of at least 1 stenosis ≥70% in a native coronary artery in whom PCI is considered based on clinical grounds

You may not qualify if:

  • refusal or inability to provide written informed consent
  • subjects in whom the quality of coronary CTA is insufficient
  • bifurcation lesions, by which strategies other than a single cross-over stent technique are anticipated
  • left main coronary artery stenosis
  • chronic total occlusion
  • in-stent restenosis
  • chronic renal failure (estimated glomerular filtration rate \<30 ml/min)
  • known allergy to contrast
  • untreated hyperthyroidism
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VU University Medical Center Amsterdam

Amsterdam, De Boelelaan 1117, 1081 HV, Netherlands

RECRUITING

MeSH Terms

Conditions

Coronary Artery DiseaseCoronary Stenosis

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Central Study Contacts

Maksymilian P. Opolski, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

May 8, 2018

First Posted

May 21, 2018

Study Start

April 25, 2018

Primary Completion

September 1, 2018

Study Completion

December 1, 2018

Last Updated

May 22, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

Locations